PDCD1 and neoplasm: Therefore, efficient T lymphocyte tumor infiltration, improved tumor immunosuppressive microenvironment, and enhanced tumor accumulation and penetration of anti-PD-1/PD-L1 antibody are required to increase the potential responses to anti-PD-1/PD-L1 antibody.